387 related articles for article (PubMed ID: 29448513)
21. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
Guo B; Zhong S; Li N; Li X; Yi J; Jin M
Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855
[TBL] [Abstract][Full Text] [Related]
22. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
Hu L; Zhang H; Song W; Gu D; Hu Q
Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
[TBL] [Abstract][Full Text] [Related]
23. Tedizolid-Cyclodextrin System as Delayed-Release Drug Delivery with Antibacterial Activity.
Paczkowska-Walendowska M; Rosiak N; Tykarska E; Michalska K; Płazińska A; Płaziński W; Szymanowska D; Cielecka-Piontek J
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374358
[TBL] [Abstract][Full Text] [Related]
24. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
25. New chromatographic insights on drug:cyclodextrin inclusion complexes and their potential use in drug delivery.
Constantin M; Cosman B; Ascenzi P; Simionescu BC; Fundueanu G
Expert Opin Drug Deliv; 2022 Dec; 19(12):1696-1709. PubMed ID: 36372064
[TBL] [Abstract][Full Text] [Related]
26. The interaction mechanism of oligopeptides containing aromatic rings with β-cyclodextrin and its derivatives.
Li J; Geng S; Wang Y; Lv Y; Wang H; Liu B; Liang G
Food Chem; 2019 Jul; 286():441-448. PubMed ID: 30827631
[TBL] [Abstract][Full Text] [Related]
27. [Preparation, identification and thermodynamic stability of capsaicin-hydroxypropyl-beta-cyclodextrin inclusion compound].
Chen X; Zhang Z; Ren K; Gong T
Zhongguo Zhong Yao Za Zhi; 2009 Feb; 34(4):394-7. PubMed ID: 19459297
[TBL] [Abstract][Full Text] [Related]
28. The formation of a host-guest inclusion complex system between β-cyclodextrin and baicalin and its dissolution characteristics.
Li J; Jiang Q; Deng P; Chen Q; Yu M; Shang J; Li W
J Pharm Pharmacol; 2017 Jun; 69(6):663-674. PubMed ID: 28299800
[TBL] [Abstract][Full Text] [Related]
29. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.
Chierentin L; Garnero C; Chattah AK; Delvadia P; Karnes T; Longhi MR; Salgado HR
AAPS PharmSciTech; 2015 Jun; 16(3):683-91. PubMed ID: 25511811
[TBL] [Abstract][Full Text] [Related]
30. Complexation of steroid hormones with cyclodextrin derivatives: substituent effects of the guest molecule on solubility and stability in aqueous solution.
Albers E; Müller BW
J Pharm Sci; 1992 Aug; 81(8):756-61. PubMed ID: 1403720
[TBL] [Abstract][Full Text] [Related]
31. Inclusion complexes of tea polyphenols with HP-β-cyclodextrin:Preparation, characterization, molecular docking, and antioxidant activity.
Zhong Y; Li W; Ran L; Hou R; Han P; Lu S; Wang Q; Zhao W; Zhu Y; Dong J
J Food Sci; 2020 Apr; 85(4):1105-1113. PubMed ID: 32175596
[TBL] [Abstract][Full Text] [Related]
32. Cyclodextrin derivatives in pharmaceutics.
Albers E; Müller BW
Crit Rev Ther Drug Carrier Syst; 1995; 12(4):311-37. PubMed ID: 9501966
[TBL] [Abstract][Full Text] [Related]
33. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
Zhang X; Zhang T; Lan Y; Wu B; Shi Z
AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
[TBL] [Abstract][Full Text] [Related]
34. Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity.
Tang P; Li S; Wang L; Yang H; Yan J; Li H
Carbohydr Polym; 2015 Oct; 131():297-305. PubMed ID: 26256188
[TBL] [Abstract][Full Text] [Related]
35. Effect of hydrotropic substances on the complexation of sparingly soluble drugs with cyclodextrin derivatives and the influence of cyclodextrin complexation on the pharmacokinetics of the drugs.
Müller BW; Albers E
J Pharm Sci; 1991 Jun; 80(6):599-604. PubMed ID: 1834826
[TBL] [Abstract][Full Text] [Related]
36. Inclusion complex of ITH12674 with 2-hydroxypropyl-β-cyclodextrin: Preparation, physical characterization and pharmacological effect.
Michalska P; Wojnicz A; Ruiz-Nuño A; Abril S; Buendia I; León R
Carbohydr Polym; 2017 Feb; 157():94-104. PubMed ID: 27988012
[TBL] [Abstract][Full Text] [Related]
37. Fast dissolving cyclodextrin complex of piroxicam in solid dispersion part I: influence of β-CD and HPβ-CD on the dissolution rate of piroxicam.
Bouchal F; Skiba M; Chaffai N; Hallouard F; Fatmi S; Lahiani-Skiba M
Int J Pharm; 2015 Jan; 478(2):625-32. PubMed ID: 25522828
[TBL] [Abstract][Full Text] [Related]
38. Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin.
Evrard B; Chiap P; DeTullio P; Ghalmi F; Piel G; Van Hees T; Crommen J; Losson B; Delattre L
J Control Release; 2002 Dec; 85(1-3):45-50. PubMed ID: 12480310
[TBL] [Abstract][Full Text] [Related]
39. [Preparation, identification and inclusion actions of irisquinone hydroxypropyl-beta-cyclodextrin inclusion complex].
Zhang XN; Yan XY; Tang LH; Gong JH; Zhang Q
Yao Xue Xue Bao; 2005 Apr; 40(4):369-72. PubMed ID: 16011270
[TBL] [Abstract][Full Text] [Related]
40. Dasatinib/HP-β-CD Inclusion Complex Based Aqueous Formulation as a Promising Tool for the Treatment of Paediatric Neuromuscular Disorders.
Cutrignelli A; Sanarica F; Lopalco A; Lopedota A; Laquintana V; Franco M; Boccanegra B; Mantuano P; De Luca A; Denora N
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
